Cite

HARVARD Citation

    Lacouture, M. et al. (2022). Management of Dermatologic Events Associated With the Nectin-4-directed Antibody-Drug Conjugate Enfortumab Vedotin. Oncologist. pp. e223-e232. [Online]. 
  
Back to record